AGENUS INC (AGEN) awards 100,000 stock options to its CMO
Rhea-AI Filing Summary
AGENUS INC reported that Chief Medical Officer Steven J. O'Day received a grant of 100,000 stock options on 2026-08-05. The options have an exercise price of $7.7800 per share, expire on 2036-08-05, and were awarded under the 2019 Amended and Restated Equity Incentive Plan. They vest over three years, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds vesting in two equal annual installments thereafter.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
O'Day Steven J
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 100,000 shares (Direct)
Footnotes (1)
- F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
Key Figures
Stock options granted: 100,000 options
Exercise price: $7.7800 per share
Expiration date: 2036-08-05
+2 more
5 metrics
Stock options granted
100,000 options
Grant to Chief Medical Officer on 2026-08-05
Exercise price
$7.7800 per share
Conversion or exercise price of stock option grant
Expiration date
2036-08-05
Stock option grant expires on this date
Vesting period
3 years
Options vest over three years from the grant date
Underlying common shares
100,000 shares
Underlying Agenus common stock covered by the options
Key Terms
Stock Option, Equity Incentive Plan, vesting, Grant Date
4 terms
Stock Option financial
"Security title reported as Stock Option for the grant"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Equity Incentive Plan financial
"Option awarded under the 2019 Amended and Restated Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"Options vest over three years, with one-third vesting after one year"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant Date financial
"One-third vesting on the first anniversary of the Grant Date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Agenus (AGEN) report for Steven J. O'Day?
Agenus reported that Chief Medical Officer Steven J. O'Day received a grant of 100,000 stock options on 2026-08-05. The options were issued as a compensation award under the company’s 2019 Amended and Restated Equity Incentive Plan.
How many stock options were granted to the Agenus (AGEN) CMO and at what exercise price?
Steven J. O'Day was granted 100,000 stock options with an exercise price of $7.7800 per share. These options give him the right to purchase Agenus common stock at that price if and when they are exercised.
When do Steven J. O'Day’s Agenus (AGEN) stock options expire?
The granted stock options expire on 2036-08-05. After this expiration date, any unexercised options from this 100,000-unit grant will no longer be exercisable for Agenus common stock.
What is the vesting schedule for the Agenus (AGEN) stock options granted to the CMO?
The options vest over three years: one-third vests on the first anniversary of the grant date, and the remaining two-thirds vest in two equal annual installments thereafter, subject to the terms of the equity incentive plan.
Does this Agenus (AGEN) Form 4 show any stock sales by the CMO?
No stock sales are reported; the Form 4 shows only a grant of 100,000 stock options to Steven J. O'Day. The transaction is categorized as a grant, award, or other acquisition of derivative securities.